Registry of Patients With AQP4+ NMOSD Treated With Alexion C5 Inhibitor Therapies

RecruitingOBSERVATIONAL
Enrollment

122

Participants

Timeline

Start Date

February 1, 2024

Primary Completion Date

March 4, 2030

Study Completion Date

March 4, 2030

Conditions
Neuromyelitis Optica Spectrum DisorderNMOSDAQP4+ NMOSD
Trial Locations (33)

20010

RECRUITING

Clinical Trial Site, Washington D.C.

27599

NOT_YET_RECRUITING

Clinical Trial Site, Chapel Hill

43215

RECRUITING

Clinical Trial Site, Columbus

53215

RECRUITING

Clinical Trial Site, Milwaukee

75024

RECRUITING

Clinical Trial Site, Plano

02114

RECRUITING

Research Site, Boston

Unknown

RECRUITING

Clinical Trial Site, Buenos Aires

NOT_YET_RECRUITING

Clinical Trial Site, Buenos Aires

RECRUITING

Clinical Trial Site, Buenos Aires

RECRUITING

Clinical Trial Site, Buenos Aires

RECRUITING

Clinical Trial Site, Burnaby

NOT_YET_RECRUITING

Clinical Trial Site, Beijing

NOT_YET_RECRUITING

Clinical Trial Site, Guangzhou

NOT_YET_RECRUITING

Clinical Trial Site, Henan

NOT_YET_RECRUITING

Clinical Trial Site, Shanghai

NOT_YET_RECRUITING

Clinical Trial Site, Sichuan

NOT_YET_RECRUITING

Clinical Trial Site, Wuhan

RECRUITING

Clinical Trial Site, Dresden

RECRUITING

Clinical Trial Site, Essen

NOT_YET_RECRUITING

Clinical Trial Site, München

RECRUITING

Clinical Trial Site, Naples

RECRUITING

Clinical Trial Site, Fukuoka

RECRUITING

Clinical Trial Site, Kawasaki

RECRUITING

Clinical Trial Site, Miyagi

NOT_YET_RECRUITING

Clinical Trial Site, Tokyo

RECRUITING

Clinical Trial Site, Daejeon

RECRUITING

Clinical Trial Site, Gyeonggi-do

RECRUITING

Clinical Trial Site, Seoul

RECRUITING

Clinical Trial Site, Seoul

RECRUITING

Clinical Trial Site, Seoul

RECRUITING

Clinical Trial Site, Seoul

RECRUITING

Clinical Trial Site, Seoul

RECRUITING

Clinical Trial Site, Seoul

Sponsors
All Listed Sponsors
lead

Alexion Pharmaceuticals, Inc.

INDUSTRY